Neonatal Intensive Care
前往频道在 Telegram
Neonatal Intensive Care Channel @newborn Administrator: @Vafaeeali Technical Supervisor of the Channel: Ali Vafaee, M.Sc. in Neonatal Intensive Care Ph.D. Candidate in Nursing Ms. Aida Safaei Fakhr M.Sc. in Neonatal Intensive Care
显示更多📈 Telegram 频道 Neonatal Intensive Care 的分析概览
频道 Neonatal Intensive Care (@newborn) 英语 语言赛道中的 是活跃参与者。目前社区聚集了 17 902 名订阅者，在 医学 类别中位列第 1 360，并在 伊朗 地区排名第 19 277 位。
📊 受众指标与增长动态
自 невідомо 创建以来，项目保持高速增长，吸引了 17 902 名订阅者。
根据 22 十月, 2026 的最新数据，频道保持稳定运转。过去 30 天订阅人数变化为 127，过去 24 小时变化为 8，整体触达仍然可观。
- 认证状态： 未认证
- 互动率 (ER)： 平均受众互动率为 18.63%。内容发布后 24 小时内通常能获得 5.54% 的反应，占订阅者总量。
- 帖子覆盖： 每篇帖子平均可获得 3 334 次浏览，首日通常累积 991 次浏览。
- 互动与反馈： 受众积极参与，单帖平均反应数为 14。
- 主题关注点： 内容集中在 است, مراقبت, نوزادان, برای, نوزاد 等核心主题上。
📝 描述与内容策略
作者将该频道定位为表达主观观点的平台：
“Neonatal Intensive Care Channel
@newborn
Administrator: @Vafaeeali
Technical Supervisor of the Channel:
Ali Vafaee, M.Sc. in Neonatal Intensive Care
Ph.D. Candidate in Nursing
Ms. Aida Safaei Fakhr M.Sc. in Neonatal Intensive Care”
凭借高频更新（最新数据采集于 23 十月, 2026），频道始终保持新鲜度与高覆盖。分析显示受众积极互动，使其成为 医学 类别中的关键影响点。
17 902
订阅者
+824 小时
+417 天
+12730 天
帖子存档
17 902
🔴🔵🟣
Please members with premium accounts boost our channel. Thank you very much.
https://t.me/boost/newborn
https://t.me/boost/newborn
https://t.me/boost/newborn
17 902
Repost from Pediatrics & Neonatology Journals [Ahmed Manfy]
Park's Pediatric Cardiology for Practitioners, Eighth Edition 2027 #Exclusive_Books
Thanks to My lovely Wife for great effort ❤️
17 902
Repost from Pediatrics & Neonatology Journals [Ahmed Manfy]
IAP_Textbook_of_Pediatric_and_Neonatal_Emergencies_afkebooks_com.pdf45.07 MB
17 902
Repost from Pediatrics & Neonatology Journals [Ahmed Manfy]
Red_Book_Atlas_of_Pediatric_Infectious_Diseases_American_Academy.pdf428.27 MB
17 902
17 902
🫁 Can a ventilator adjust oxygen by itself?
One of the major challenges in caring for extremely preterm infants is maintaining SpO₂ within the target range.
Both hypoxemia and hyperoxemia can be harmful. Therefore, NICU clinicians continuously adjust the FiO₂ according to changes in the infant’s oxygen saturation.
But what if the machine could do this automatically?
🔬 What does the latest evidence show?
A large multicenter randomized controlled trial published in The Lancet Child & Adolescent Health evaluated automatic versus manual oxygen control in extremely preterm infants.
The study included more than 1,000 infants born at 23–27+6 weeks of gestation across 32 NICUs.
In the intervention group, a closed-loop automated FiO₂ control system continuously used SpO₂ data to adjust the oxygen concentration.
Interestingly, the primary clinical outcome was not significantly different:
🔹 Death, NEC, BPD, or severe ROP:
39% with automated oxygen control
vs.
41% with manual control
There was also no significant difference in the individual outcomes of:
• Mortality
• Necrotizing enterocolitis (NEC)
• Bronchopulmonary dysplasia (BPD)
• Severe retinopathy of prematurity (ROP)
📌 So, does automated oxygen control not work?
Not necessarily.
Previous studies have shown that closed-loop systems can increase the amount of time infants spend within the target SpO₂ range and may reduce episodes of both hypoxemia and hyperoxemia.
They may also reduce the workload associated with frequent manual FiO₂ adjustments.
However, the 2026 trial suggests that better oxygen targeting does not automatically translate into better major clinical outcomes.
⚠️ Clinical message
Automated FiO₂ control should not be considered a replacement for clinical judgment.
The technology may become an important tool for reducing oxygen fluctuations and supporting bedside clinicians, but careful monitoring and appropriate clinical decision-making remain essential.
🔑 The future of neonatal oxygen therapy may not be
Human vs. machine
but rather:
Human + intelligent technology.
The goal is not simply to achieve a target SpO₂ value, but to minimize the dangerous swings between hypoxemia and hyperoxemia.
📚 Reference
Franz AR, Maiwald CA, Niemarkt HJ, et al. Automatic versus manual control of oxygen and neonatal clinical outcomes in extremely preterm infants: a multicentre, parallel-group, randomised, controlled, superiority trial. Lancet Child Adolesc Health. 2026;10(3):179–188. doi:10.1016/S2352-4642(25)00351-7.
@newborn
@newborn
17 902
Repost from NeoFast | Neonatal prescription
Therapeutic Hypothermia in Neonatal HIE: Clinical Criteria, 72-Hour Protocol, and Systems Management
Therapeutic hypothermia in neonatal HIE: Clinical criteria, 72-hour protocol, and systems management
- Inclusion: GA ≥36w, age ≤6h, pH≤7.0/BE≥-16, moderate-severe Sarnat
- Cool to 33.5±0.5°C for 72h; monitor q15min first 4h then q1h; rewarm ≤0.5°C per 1-2h
- Dexmedetomidine for shivering, low-dose opioids; MAP 40-50 mmHg; glucose 2.6-8.0 mmol/L
- Abort: refractory hypotension on inotropes, persistent hypoxemia despite 100% O2/iNO, severe coagulopathy
Read the full guide on NeoFast
17 902
Neonatal_Disease_From_Pathophysiology_to_Current_and_Emerging_Therapeutic.pdf19.74 MB
17 902
Repost from NeoFast | Neonatal prescription
Optimizing Neurodevelopment in Severe Bronchopulmonary Dysplasia: BSRI and OSST Scores in NICU Chronic Care
Chronic care scoring for severe BPD: BSRI and OSST scales replace aggressive weaning with structured, brain-protective monitoring.
- BSRI: 5-item bedside tolerance score (Interaction, Midline, Extension, Tachypnea, Respiratory Effort); score ≥8 = proceed, lower = stop handling.
- Tachypnea cutoffs: RR >80/min or tachypnea-apnea = instability; RR <60/min = stable.
- OSST: weekly 4-domain score (Respiratory, Neuroregulation, Infection/Inflammation, Nutrition/Growth).
- CCBPD model cut Bayley <70 rates: cognitive/language 49.8% to 15.2%, motor delay 41.7% to 10.9%, no rise in accidental extubation.
Read the full guide on NeoFast
17 902
Repost from NeoFast | Neonatal prescription
Neonatal Vascular Access: UVC & IO – Indications, Timing, and Team Coordination in Advanced Resuscitation
UVC and intraosseous access for emergency neonatal resuscitation
- HR < 60 bpm after 60 seconds compressions with 100% oxygen; establish UVC or IO access
- UVC preferred; IO alternative when UVC not feasible; epinephrine every 3-5 minutes
- IO insertion 2 cm below and 1-2 cm medial to tibial tuberosity; flush with 3-5 mL NS
- Compressor moves to head of bed to free space for UVC insertion
Read the full guide on NeoFast
17 902
Repost from NeoFast | Neonatal prescription
The Neonatal Resuscitation Blueprint: A Visual Guide to the First 60 Seconds (NRP 9th Edition)
NRP 9th algorithm for first 60 seconds: warm, assess, escalate by HR thresholds.
- Target HR >100 bpm; <60 bpm requires 3:1 compressions + 100% oxygen
- Epinephrine 0.1 mg/mL via UVC/IO every 3-5 min if HR <60 bpm
- Ventilation 40-60 breaths/min; PIP 20-30 cm H2O, PEEP 5 cm H2O
- SpO2 targets: 60-70% at 2 min, 70-75% at 3 min, 75-80% at 4 min, 80-85% at 5 min, 85-95% at 10 min
- Initial FiO2: 21% (≥35 wks), 21-30% (32-34 wks), ≥30% (<32 wks)
Read the full guide on NeoFast
17 902
Repost from NeoFast | Neonatal prescription
Critical Management of Neonatal Hyperbilirubinemia: From AAP 2022 Guideline to Bedside Decision with Neofast
Neonatal hyperbilirubinemia: AAP 2022 thresholds and risk factors
- Phototherapy 8.9 mg/dL, escalation 14.1 mg/dL, exchange transfusion 20.0 mg/dL
- Risk factors lower thresholds: gestational age <38w, albumin <3.0 g/dL, hemolytic disease, G6PD, sepsis
- IVIG 400-1000 mg/kg/dose for positive Coombs; intensive phototherapy ≥30 μW/cm²/nm reduces bilirubin 30-40% in 24h
- Exchange transfusion: 170 mL/kg, removes 85% RBCs, monitor bilirubin every 2 hours
Read the full guide on NeoFast
17 902
Repost from NeoFast | Neonatal prescription
Severe MAS & APHN: The Advanced Management Protocol
Advanced management of severe meconium aspiration and neonatal pulmonary hypertension
- SpO2 91-95% pre-ductal, PaCO2 6-8 kPa; >10% pre/post-ductal gradient confirms shunting
- Milieu: ionized calcium >1.0, magnesium ≥1.0 mmol/L, hemoglobin ≥120 g/L
- OI >20: iNO 20 ppm + HFOV; OI >40: ECLS/ECMO referral
- Inotropes: Milrinone 0.25 mcg/kg/min or Dobutamine 5-10 + Adrenaline 0.05-0.2 mcg/kg/min; Hydrocortisone 2.5 mg/kg 6-hourly if refractory
Read the full guide on NeoFast
